Scynexis (SCYX) Return on Capital Employed (2014 - 2026)
Scynexis (SCYX) reported Return on Capital Employed of 19.3% for Q1 2026, up 3221.0% on a YoY basis from 0.58% in Q1 2025, and down 432.49% quarter-over-quarter from 3.62% in Q4 2025.
Scynexis (SCYX) Return on Capital Employed (2014 - 2026) Analysis & Trends
Scynexis has reported Return on Capital Employed for 13 years, with the latest figure at 19.3% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 3221.0% year-over-year to 19.3%; the trailing twelve-month figure through Mar 2026 stood at 19.3% (up 3221.0% YoY), and the FY2025 full-year result was 2.61%, up 4083.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 19.3%, down from 3.62% in the prior quarter.
- The five-year high for Return on Capital Employed was 76.93% in Q1 2024, with the low at 229.58% in Q1 2023.
- Historically, Return on Capital Employed has averaged 32.74% across 5 years, with a median of 29.64% in 2022.
- Annual changes were most pronounced in 2023 — Return on Capital Employed slumped 20435 bps — and 2024, when it soared 30652 bps.
- Scynexis' Return on Capital Employed stood at 104.03% in 2022, then surged by 157 bps to 59.48% in 2023, then plunged by 188 bps to 52.47% in 2024, then jumped by 93 bps to 3.62% in 2025, then plunged by 432 bps to 19.3% in 2026.
- The last three Return on Capital Employed figures came in at 19.3% (Q1 2026), 3.62% (Q4 2025), and 73.04% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - | -19.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.30% |
| Dec 31, 2025 | -3.62% |
| Sep 30, 2025 | -73.04% |
| Jun 30, 2025 | -68.38% |
| Mar 31, 2025 | -51.51% |
| Dec 31, 2024 | -52.47% |
| Sep 30, 2024 | -67.09% |
| Jun 30, 2024 | -59.12% |
| Mar 31, 2024 | 76.93% |
| Dec 31, 2023 | 59.48% |
| Sep 30, 2023 | 54.30% |
| Jun 30, 2023 | 63.84% |
| Mar 31, 2023 | -229.58% |
| Dec 31, 2022 | -104.03% |
| Sep 30, 2022 | -29.64% |
| Jun 30, 2022 | -28.03% |
| Mar 31, 2022 | -25.23% |
| Dec 31, 2021 | -7.69% |
| Sep 30, 2021 | -14.65% |
| Jun 30, 2021 | -7.77% |